XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.25.3

Net income (loss) per share | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Net income (loss) per share | 7. Net income (loss) per share Basic and diluted net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding. The following tables set forth the computation of basic and diluted net income (loss) per share: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | ​ | Nine Months Ended September 30, | ​
​ |  | 2025 |  | 2024 |  | ​ | 2025 |  | 2024 |
Numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss), basic | ​ | $ | 15,896 |  | $ | (106,654) | ​ |  | ​ | $ | 817,609 |  | $ | (297,409) |
Add: Interest expense, net of tax, on the Company's 2026 Convertible Notes | ​ | ​ | 1,096 | ​ | ​ | — | ​ | ​ | ​ | ​ | 3,257 | ​ | ​ | — | ​
Net income (loss), diluted | ​ | $ | 16,992 | ​ | $ | (106,654) | ​ | ​ | ​ | $ | 820,866 | ​ | $ | (297,409) | ​
Denominator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted-average number of shares outstanding, basic | ​ | ​ | 78,471,119 |  | ​ | 76,925,523 | ​ |  | ​ |  | 78,642,478 |  |  | 76,716,340 |
Effect of dilutive securities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Common stock issuable under the Company's equity incentive plans | ​ |  | 3,170,135 | ​ |  | — | ​ | ​ | ​ | ​ | 2,783,134 | ​ | ​ | — | ​
Common stock issuable under the Company's 2026 Convertible Notes | ​ | ​ | 5,474,115 | ​ | ​ | — | ​ | ​ | ​ | ​ | 5,474,115 | ​ | ​ | — | ​
Weighted-average common shares outstanding, diluted | ​ | ​ | 87,115,369 | ​ | ​ | 76,925,523 | ​ | ​ | ​ | ​ | 86,899,727 | ​ | ​ | 76,716,340 | ​
Net income (loss) per common share, basic | ​ | $ | 0.20 | ​ | $ | (1.39) | * | ​ | ​ | $ | 10.40 | ​ | $ | (3.88) | *
Net income (loss) per common share, diluted | ​ | $ | 0.20 | ​ | $ | (1.39) | * | ​ | ​ | $ | 9.45 | ​ | $ | (3.88) | *
* In the three and nine months ended September 30, 2024, the Company experienced a net loss and therefore did not report any dilutive share impact. The following table shows historical common share equivalents outstanding, which are not included in the above calculation, as the effect of their inclusion is anti-dilutive during each period. The anti-dilutive shares are calculated as the unweighted outstanding shares as of the reporting period end date that are antidilutive using the treasury stock method. ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of September 30, | ​
​ |  | 2025 |  | 2024 |
Stock options | ​ | 2,282,923 | ​ | 9,173,460 | ​
Unvested restricted stock units |  | 3,788,803 |  | 3,596,329 |
Total |  | 6,071,726 |  | 12,769,789 |
​

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration